Novel applications of diagnostic x-rays in activating photo-agents through x-ray induced visible luminescence from rare-earth particles: an in vitro study

Erkinay Abliz; Joshua E. Collins; Joseph S. Friedberg; Ajith Kumar; Howard Bell; Ronald W. Waynant; Darrell B. Tata

doi:10.1117/12.846680

11 February 2010 Novel applications of diagnostic x-rays in activating photo-agents through x-ray induced visible luminescence from rare-earth particles: an in vitro study

Erkinay Abliz, Joshua E. Collins, Joseph S. Friedberg, Ajith Kumar, Howard Bell, Ronald W. Waynant, Darrell B. Tata

Author Affiliations +

Proceedings Volume 7565, Biophotonics and Immune Responses V; 75650B (2010) https://doi.org/10.1117/12.846680
Event: SPIE BiOS, 2010, San Francisco, California, United States

Abstract

Photodynamic agents such as Photofrin II (Photo II) utilized in photodynamic therapy (PDT) possess a remarkable property to become preferentially retained within the tumor's micro-environment. Upon the photo-agent's activation through visible light photon absorption, the agents exert their cellular cytotoxicity through type II and type I mechanistic pathways through extensive generation of reactive oxygen species (ROS): singlet oxygen ¹O₂, superoxide anion O₂ -, and hydrogen peroxide H₂O₂, within the intratumoral environment. Unfortunately, due to shallow visible light penetration depth (~2mm to 5mm) in tissues, the PDT strategy currently has largely been restricted to the treatments of surface tumors, such as the melanomas. Additional invasive strategies through optical fibers are currently utilized in getting the visible light into the intended deep seated targets within the body for PDT. In this communication, we report on a novel strategy in utilizing "soft" energy diagnostic X-rays to indirectly activate Photo II through X-ray induced luminescence from Gadolinium oxysulfide (20 micron dimension) particles doped with Terbium: Gd₂O₂S:Tb. X-ray induced visible luminescence from Gd₂O₂S:Tb particles was spectroscopically characterized and the ROS production levels from clinically relevant concentration (10 μg/ml) of Photo II was quantified through changes in the Vitamin C absorbance. ROS kinetics through X-ray induced luminescence was found to be similar to the ROS kinetics from red He-Ne laser exposures used in the clinics. Taken together, in-vitro findings herein provide the basis for future studies in determining the safety and efficacy of this non-invasive X-ray induced luminescence strategy in activating photo-agent in deep seated tumors.

Citation Download Citation

Erkinay Abliz, Joshua E. Collins, Joseph S. Friedberg, Ajith Kumar, Howard Bell, Ronald W. Waynant, and Darrell B. Tata "Novel applications of diagnostic x-rays in activating photo-agents through x-ray induced visible luminescence from rare-earth particles: an in vitro study", Proc. SPIE 7565, Biophotonics and Immune Responses V, 75650B (11 February 2010); https://doi.org/10.1117/12.846680

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available